Cardiovascular disease (CVD) is the most common cause of death in the United States of America, accounting for 24% of all deaths each year,(Anderson et al., 2003) and is projected to rise above 20% globally by 2030.(Mathers and Loncar, 2006) Options for CVD treatment do exist, but are limited by availability of healthy replant tissue from the patient or long term effectiveness and failure rates of both autologous tissue grafts and artificial implants. Grafting failure may often be attributed to the poor mimicry of the site-specific, healthy arterial tissue. While much TEVG research focuses on endothelialization of the graft lumen through chemical signaling, mechanotransduction plays a large role in forming and maintaining a healthy endothelial cell (EC) monolayer. Arteries and grafts interact with hemodynamics to determine flow pulsatility and create healthy, or pathological, mechanical signaling environments. Though arterial tissue is known to be viscoelastic,(Armentano et al., 2006; Bergel, 1961; Bia et al., 2006) the importance of this in developing healthy blood flow is undetermined. Therefore, a gap in the knowledge occurs in the importance of arterial mechanics affecting graft outcomes. To address this we attempt to examine specific shortcomings: 1) Determine whether pathological flow is capable of maintaining EC monolayer in a low arterial compliance model, 2) Establish methods of catering protein hydrogel frequency-dependent properties towards establishing biodegradable materials intended for TEVG, 3) Determine benefits of viscous wall damping in improving hemodynamics towards improved cell response. This proposal centers on improving cell response to pathological hemodynamics through catered viscoelastic material response at the arterial wall. To address this, we hypothesize that maintaining healthy EC monolayer is predicated on hemodynamic mechanotransduction, which results from both graft compliance and viscous damping of the material. To validate this hypothesis, we examine healthy and pathological hemodynamic effects on EC monoculture, and systematically determine the role of viscoelastic material response in maintaining healthy hemodynamics.

Effect of Tissue Viscoelasticity and Stiffness on Hemodynamics and Endothelial Cell Signaling / Elliott, Winston Howard. - (2017), pp. 1-157.

Effect of Tissue Viscoelasticity and Stiffness on Hemodynamics and Endothelial Cell Signaling

Elliott, Winston Howard
2017-01-01

Abstract

Cardiovascular disease (CVD) is the most common cause of death in the United States of America, accounting for 24% of all deaths each year,(Anderson et al., 2003) and is projected to rise above 20% globally by 2030.(Mathers and Loncar, 2006) Options for CVD treatment do exist, but are limited by availability of healthy replant tissue from the patient or long term effectiveness and failure rates of both autologous tissue grafts and artificial implants. Grafting failure may often be attributed to the poor mimicry of the site-specific, healthy arterial tissue. While much TEVG research focuses on endothelialization of the graft lumen through chemical signaling, mechanotransduction plays a large role in forming and maintaining a healthy endothelial cell (EC) monolayer. Arteries and grafts interact with hemodynamics to determine flow pulsatility and create healthy, or pathological, mechanical signaling environments. Though arterial tissue is known to be viscoelastic,(Armentano et al., 2006; Bergel, 1961; Bia et al., 2006) the importance of this in developing healthy blood flow is undetermined. Therefore, a gap in the knowledge occurs in the importance of arterial mechanics affecting graft outcomes. To address this we attempt to examine specific shortcomings: 1) Determine whether pathological flow is capable of maintaining EC monolayer in a low arterial compliance model, 2) Establish methods of catering protein hydrogel frequency-dependent properties towards establishing biodegradable materials intended for TEVG, 3) Determine benefits of viscous wall damping in improving hemodynamics towards improved cell response. This proposal centers on improving cell response to pathological hemodynamics through catered viscoelastic material response at the arterial wall. To address this, we hypothesize that maintaining healthy EC monolayer is predicated on hemodynamic mechanotransduction, which results from both graft compliance and viscous damping of the material. To validate this hypothesis, we examine healthy and pathological hemodynamic effects on EC monoculture, and systematically determine the role of viscoelastic material response in maintaining healthy hemodynamics.
2017
XXVII
2018-2019
Ingegneria industriale (29/10/12-)
Materials Science and Engineering
Migliaresi, Claudio
Tan, Wei
no
Inglese
Settore ING-IND/34 - Bioingegneria Industriale
File in questo prodotto:
File Dimensione Formato  
WinstonElliott_Dissertation(Final-2).pdf

Solo gestori archivio

Tipologia: Tesi di dottorato (Doctoral Thesis)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 6.04 MB
Formato Adobe PDF
6.04 MB Adobe PDF   Visualizza/Apri
Disclaimer.pdf

Solo gestori archivio

Tipologia: Tesi di dottorato (Doctoral Thesis)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 371.83 kB
Formato Adobe PDF
371.83 kB Adobe PDF   Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11572/368196
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact